The secrets of the immune system explored using Nobel prize-winning technology
During a conference at Karolinska Institutet, researchers will discuss how new technology may contribute to advancements within immunology. These advancements may in turn have a major impact on the treatment of diseases such as cancer, rheumatoid arthritis and multiple sclerosis.
Journalists are welcome to attend the conference and interview the participants. Conference: Novel fluorescence-based methods in immunology Time: 9-10 February 2015 Place: Stockholm, Karolinska Institutet Campus Solna, Tomtebodavägen 6, Samuelsson Lecture Hall. The inventors of the nanoscope were awarded the Nobel Prize in Chemistry last year. The new technology of super-resolved fluorescence microscopy has made it possible to study molecules on a nanoscale. It is for example possible to look at how proteins form aggregates in Parkinson's disease, or what the connections between the nerve cells of the brain look like. This technology is now also being used within immunology to study the cells of the immune system. Much of the conference at Karolinska Institutet will be devoted to this method. In addition to a lecture by Hans Blom, KTH Royal Institute of Technology and SciLifeLab, Eilon Sherman, The Hebrew University of Jerusalem, Israel, will also talk about how immunology can benefit from this technology. There are also several other methods based on fluorescent light. Theo Lasser, EPFL, Lausanne, Switzerland, will talk more about this in his lecture Seeing is believing. The whole conference focuses on how technologies such as these can be used to study the molecular dynamics of the immune system. Subjects include the movement of immune cells and how they are controlled in terms of time and space. Using these new methods, it is possible to find out where on the surface of the cells the receptors are placed and how these signal and activate the cells. "Molecular dynamics is a relatively new concept in immunology. The fact that the cells of the immune system are mobile is a great difference compared to other cells. The immune cells course through the body, scanning other cells to see if there are any foreign substances found. Using these new fluorescent technologies we can learn much more about the cells than we could with previous methods,” says Sofia Johansson, Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, who is organising the conference together with Elina Staaf from the same department. Björn Önfelt, KTH and SciLifeLab, has developed a method that allows researchers to study a single cell and the activity that takes place around it. This is made possible through a microchip that contains a great number of wells, where one cell is placed in each well. More on this subject during the conference. These methods will to a great extent be used for basic research within immunology. By extension, this will also lead to improved diagnosis and treatment of diseases. There are already cell-based methods of cancer treatment. It is possible to transplant immune cells between people. It is also possible to extract a patient's own cells, treat them outside of the body and then retransplant them into the patient. These are areas that can be expanded with the help of the new knowledge that is being developed. Programmex If you have any questions, please contact: Research Associate Sofia Johansson +46 73-634 16 48 sofia.e.johansson@ki.se Postdoc Elina Staaf +46 8-524 863 70 elina.staaf@ki.se Press Officer Sabina Bossi +46 8-524 860 66 or +46 70-614 60 66 sabina.bossi@ki.se
Karolinska Institutet (http://ki.se/english) is one of the world's leading medical universities. Its vision is to significantly contribute to the improvement of human health. Karolinska Institutet accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country´s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.
Subscribe to releases from Karolinska Institutet - English
Subscribe to all the latest releases from Karolinska Institutet - English by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Karolinska Institutet - English
New method reveals how the brain and inner ear are formed3.4.2025 20:00:00 CEST | Pressmeddelande
Researchers at Karolinska Institutet have developed a method that shows how the nervous system and sensory organs are formed in an embryo. By labelling stem cells with a genetic ‘barcode’, they have been able to follow the cells’ developmental journey and discover how the inner ear is formed in mice. The discovery, published in Science, could provide important insights for future treatment of hearing loss.
Fluoride in drinking water is associated with impaired childhood cognition7.3.2025 15:30:00 CET | Pressmeddelande
Elevated concentrations of fluoride can occur in well water, and in some countries, it is added to drinking water to counteract caries in the population. A study from Karolinska Institutet in Sweden now supports a few previous studies indicating that exposure to fluoride during the fetal stage or early childhood may impair cognition in children. The study is published in the journal Environmental Health Perspectives.
Children with ARFID face increased risk of disease17.2.2025 17:00:00 CET | Pressmeddelande
Children with avoidant restrictive food intake disorder (ARFID) have an elevated risk of developing psychiatric and physical conditions, a new study from Karolinska Institutet published in JAMA Pediatrics reports. The study highlights the importance of early identification to improve care of these children.
Preterm babies receive insufficient pain management27.1.2025 15:29:17 CET | Pressmeddelande
A large proportion of babies born very early need intensive care, which can be painful. But the healthcare system fails to provide pain relief to the full extent. This is shown by the largest survey to date of pain in neonatal care, now published in the journal Pain.
New study paves way for immunotherapies tailored for childhood cancers20.1.2025 17:00:00 CET | Pressmeddelande
Researchers at Karolinska Institutet and the Astrid Lindgren Children’s Hospital in Sweden have determined how children’s immune systems react to different kinds of cancer depending on their age. The study, which is published in the journal Cell, reveals significant differences between the immune response of children and adults, and has the potential to lead to new tailored treatments for children with cancer.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom